Trinity Biotech PLC 6-K, filed Oct 28, 2020
Trinity Biotech PLC (TRIB)
6-K
2020-10-28
For: 2020-10-28
View Original
Added on
July 07, 2026
About this 6-K
Trinity Biotech PLC filed this 6-K on October 28, 2020.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
F O R M 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October, 2020
TRINITY BIOTECH PLC
(Name of Registrant)
IDA Business Park
Bray, Co. Wicklow
Ireland
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule
12g3-2(b) under the Securities Exchange Act of 1934.
Yes ☐ No ☒
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _________
TRINITY BIOTECH PLC
DUBLIN, Ireland (October 28, 2020)…. Trinity Biotech plc (Nasdaq: TRIB), today announced that effective October 23, 2020, Mr. Denis Burger, resigned as
Non-Executive Director of the Company.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
TRINITY BIOTECH PLC
|
|||
|
(Registrant)
|
|||
|
By:
|
/s/ Kevin Tansley
|
||
|
Kevin Tansley
|
|||
|
Chief Financial Officer
|
|||
Date: 28 October 2020